Extreme delta brush in a patient with anti-NMDAR encephalitis.
Epileptic Disord. 2013 Dec; 15(4):461-4.ED

Abstract

Anti-N-methyl-D-aspartate receptor encephalitis is a severe, potentially treatable, disorder and prognosis depends on early recognition and prompt immunotherapy. We report a case of anti-N-methyl-D-aspartate receptor encephalitis with atypical age and gender, and a characteristic electroencephalographic pattern that supported the diagnosis. A 66-year-old male presented with psychiatric disturbances and focal seizures with alteration of consciousness, and progressed to a state of akinetic mutism. Auxiliary tests were negative or non-specific for anti-NMDAR encephalitis. Electroencephalographic monitoring revealed a unique pattern; the extreme delta brush. The patient improved with immunotherapy and was asymptomatic at six months of follow-up. Ancillary testing was positive for anti-N-methyl-D-aspartate receptor antibodies. Extreme delta brush is a recently described electroencephalographic pattern presenting in only one third of patients with anti-N-methyl-D-aspartate receptor encephalitis. The identification of this pattern, as in our case, may guide early diagnosis and treatment of anti-N-methyl-D-aspartate receptor encephalitis.

Links

Publisher Full Text
jle.com
john-libbey-eurotext.fr

Authors+Show Affiliations

Di Capua D
Epilepsy Unit, Hospital Universitario Clinico San Carlos.
García-Ptacek S
Hospital Universitario Clinico San Carlos, Madrid, Spain, Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
García-García ME
Epilepsy Unit, Hospital Universitario Clinico San Carlos.
Abarrategui B
Hospital Universitario Clinico San Carlos, Madrid, Spain.
Porta-Etessam J
Hospital Universitario Clinico San Carlos, Madrid, Spain.
García-Morales I
Epilepsy Unit, Hospital Universitario Clinico San Carlos.

MeSH

AgedAnti-N-Methyl-D-Aspartate Receptor EncephalitisAutoantibodiesEarly DiagnosisElectroencephalographyHumansMaleReceptors, N-Methyl-D-Aspartate

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

24317133